Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
HIV drug resistance testing not a priority for resource-limited settings, trial finds

Resistance testing is unlikely to improve the effectiveness of second-line HIV treatment in resource-limited settings and the introduction of routine HIV drug resistance testing is

Published
14 June 2017
By
Keith Alcorn
SA's new HIV challenge: patients who believe they've been healed

On the eve of South Africa’s national AIDS conference taking place in Durban this week, it has emerged that people are defaulting on their ARVs – often under the impression that they have been healed. According to health workers Health-e News spoke to, the issue relates to the “undetectable viral load” diagnosis patients receive when their antiretroviral therapy starts working and causes the amount of virus in their blood to drop to an extremely low level.

Published
13 June 2017
From
Citizen
Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

People who enter into a contract with their HIV healthcare provider to receive cash incentives in return for high levels of antiretroviral therapy (ART) adherence are more

Published
30 May 2017
By
Michael Carter
Nurse-led intervention improves adherence to ART and is cost-effective

An antiretroviral therapy (ART) adherence support study conducted in the Netherlands has been hailed as “an outstanding addition to the scientific literature on adherence.” Published

Published
28 March 2017
By
Michael Carter
Frame PrEP as part of a ‘healthy sex life’ for better adherence

Brief, empowering messaging around pre-exposure prophylaxis (PrEP) can lead to better medication adherence, new research has found. When PrEP counselors framed PrEP as part of a healthy sex life, new PrEP clients were significantly more likely to have high levels of adherence to the medication. This was true even among demographics that typically struggle with adherence including young people and people of color.

Published
27 March 2017
From
BETA blog
Early adherence to ART key to long-term virological outcomes

Adherence to antiretroviral therapy (ART) in the first few months after starting treatment is crucial to the long-term outcomes, French research published in the online

Published
14 March 2017
By
Michael Carter
Dutch adherence programme boosts HIV Tx success rate

Dutch researchers have developed an HIV medication adherence programme that has been successful in increasing treatment success rates by almost 18%, claiming it as the first adherence intervention in HIV care that demonstrates clinical and cost effectiveness.

Published
09 March 2017
From
Medical Brief
Time spent by people in HIV care in US with a transmissible viral load has fallen by three-quarters since 2000

A study by the US Centers for Disease Control and Prevention (CDC) presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle found

Published
18 February 2017
By
Gus Cairns
US: Should People With HIV Stock Up on Meds in Fear of Health Care Cuts?

As the Trump admimistration and Congress discuss sweeping changes to health care, should people with HIV start squirreling away their meds in case they lose access? HIV advocates say don't panic -- you'll likely be fine. But there are still things you can think about and steps you can take.

Published
13 February 2017
From
The Body
Women significantly more likely than men to have suboptimal adherence to HIV therapy

Women are more likely than men to have poor adherence to combination antiretroviral therapy (cART), according to Canadian research published in HIV Medicine. Adherence was monitored in

Published
08 February 2017
By
Michael Carter
← First12345...38Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.